Tags Archives: COVID-19

Perfusfind S.L.

MONMOUTH JUNCTION, N.J., Jan. 24, 2022 /PRNewswire/ --  (NASDAQ: ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, highlights a new publication in..

Perfusfind S.L.

Abstract Human factors and ergonomics (HF/E) is concerned with the design of work and work systems. There is an increasing appreciation of the value that HF/E can bring to enhancing..

Perfusfind S.L.

Abstract A 47-year-old man, with no medical history, was diagnosed with severe COVID-19 ARDS and pulmonary embolism. Venovenous extracorporeal membrane oxygenation (ECMO) was required for impossibility to deliver protective ventilation...

Perfusfind S.L.

This case reports on a 54-year-old male patient with known arterial hypertension who was transferred from a peripheral hospital to the National Hospital with cough and progressive respiratory distress 6..

Perfusfind S.L.

Abstract Patients with pulmonary hypertension and end-stage lung disease are fraught with high mortality while on a waiting list for lung transplant. With sometimes rapid deterioration they may require veno-arterial..

Perfusfind S.L.

This case reports on a 60-year-old male diagnosed with COVID-19 following a positive RT-PCR test, who was hospitalized with complaints of cough with mild expectoration, and worsening shortness of breath..

Perfusfind S.L.

Abstract Objective Previous studies reported a poor outcome in patients with coronavirus 2019 (COVID-19) undergoing cardiac surgery. Complications most frequently described were respiratory failure, renal failure, and thromboembolic events. In..

Perfusfind S.L.

Abstract Introduction We investigated the clinical course and outcomes of patients submitted to cardiovascular surgery in Brazil and who had developed symptoms/signs of coronavirus disease 2019 (COVID-19) in the perioperative..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is an advanced, resource-intensive form of life support for patients with severe respiratory or cardiac failure, and is typically provided within specialized centers. Prior to..

Perfusfind S.L.

Abstract Respiratory failure and systemic inflammation are paramount features of severe SARS-CoV-2 disease (COVID-19). Extracorporeal membrane oxygenation (ECMO) therapy has a potential role in patients with refractory disease. An inflammatory..

Perfusfind S.L.

This case reports on a 37-year-old female with previous Lower Segment Cesarean Section (LSCS) and a history of gestational insulin-dependent diabetes mellitus, who was admitted to hospital at 32 weeks..

Perfusfind S.L.

A 35-year-old pregnant woman (gestational age 32 weeks) admitted to hospital due to COVID-19 pneumonia and severe respiratory failure. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/12/CoW_50_2021_E_web_compressed.pdf"]  

Perfusfind S.L.

Abstract Objective:  To report the 30-day outcomes of patients with perioperative SARS-CoV-2 infection undergoing surgery in the USA. Summary background data:  Uncertainty regarding the postoperative risks of patients with severe..

Perfusfind S.L.

Abstract Newswise — November 22, 2021 –  – with no increased risk of transmitting COVID-19 transmission to ECMO transport team members following standard precautions, reports a study in the , official journal of..

Perfusfind S.L.

Abstract Objective To analyze Italian Cardiac Surgery experience during the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) identifying risk factors for overall mortality according to coronavirus disease 2019..

Perfusfind S.L.

Patient with COVID 19 and massive pulmonary embolism undergone pulmonary embolectomy with Zeraatian single incision technique.   [gallery ids="21203"]   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA..

Perfusfind S.L.

This case reports on a 47-year-old male who was admitted to the Emergency Room with tachypnea, hypotension, and post-COVID-19 mucormycosis. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/11/CoW_46_2021_E_web_compressed.pdf"]  

Perfusfind S.L.

Abstract In the US, 131,512 pregnant/peripartum women have been affected by Coronavirus Disease 2019 (COVID-19), with 200 associated deaths (0.15%) [1]. The hormonal, physiological, and immunomodulatory changes during pregnancy increase..

Perfusfind S.L.

Abstract Patients with coronavirus disease 2019 (COVID-19) can present with a large panel of cardiac manifestations, including myocardial infarction with (type 1) or without (type 2) obstructive coronary artery disease,..

Perfusfind S.L.

This case reports on a 67-year-old male patient who was transferred from the emergency department to the multidisciplinary intensive care unit due to severe respiratory failure from a newly diagnosed..

Perfusfind S.L.

This case reports on a 59-year-old SARS-CoV-2 positive male patient with a history of chronic lymphocytic leukemia (CLL), who was transferred from an external hospital to the intensive care unit..

Perfusfind S.L.

Abstract Background:  The use of extracorporeal membrane oxygenation (ECMO) in coronavirus disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and bridge to lung transplantation has been steadily increasing..

Perfusfind S.L.

Abstract When we first published our call for revisiting efforts to teach the skills of evidence-based healthcare (EBHC) back in November 2019, “COVID-19” was absent from society’s vocabulary. The aim of..

Perfusfind S.L.

Introduction Coronavirus infectious disease 2019 (COVID-19) pandemic has resulted in global disruption of cardiac surgical practice. More worrisome is the impact of COVID on cardiac surgical patients, especially in the..

Perfusfind S.L.

Patient with previous Covid 19 and pulmonary fibrosis step by step cannulation for VV ECMO with inflow from LT femoral vein and out flow confirmed into the right cavo atrial..

Perfusfind S.L.

Abstract Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to..

Perfusfind S.L.

Abstract The coronavirus disease 2019 (COVID-19) pandemic began in the United States around March 2020. Because of limited access to extracorporeal membrane oxygenation (ECMO) in the authors’ region, a mobile..

Perfusfind S.L.

Abstract Dear Editor, In the earliest phases of the pandemic, the use of extracorporeal life support in patients with severe coronavirus disease 2019 (COVID-19) was associated with disastrous outcomes. However,..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation is a modified form of cardiopulmonary bypass and a complex adult critical care therapy. No evidence appears to exist on sustaining relevant quality nursing standards during..

Perfusfind S.L.

A case of after covid 19 pancarditis specially involving right heart site with mucormycosis which us really really rare within heart undergone bicaval total inflow cannulation and valve extraction postoperative..